🔴 DXCM is trading 4.2% down today amid sensor recall concerns and broader market risk-off tone

DXCM is trading at $70.47 (4.2% down) in pre-market, giving back a portion of its recent multi-day rally.

• DexCom is facing scrutiny following a voluntary Class II recall of specific Dexcom G7 sensor lots that were stolen and potentially improperly sterilized or inaccurate.
• The company also initiated FDA enforcement Class II recalls for its iOS and WatchOS apps due to processing delays that could affect glucose alerts.
• The decline is also aligned with a wider risk-off tone in the broader market, as major indices and tech-related names are under pressure in early trading due to geopolitical tensions and AI valuation concerns.